Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Kobinger GP"'
Autor:
Wong G; Virology Unit, Institut Pasteur Du Cambodge, Pasteur Network, Phnom Penh, Cambodia., Bienes KM; Virology Unit, Institut Pasteur Du Cambodge, Pasteur Network, Phnom Penh, Cambodia., Xiii A; Department of Immunology and Microbiology, The Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: arxiii@utmb.edu., Fausther-Bovendo H; Department of Immunology and Microbiology, The Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA., Kobinger GP; Department of Immunology and Microbiology, The Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.
Publikováno v:
Antiviral research [Antiviral Res] 2024 Jun; Vol. 226, pp. 105873. Date of Electronic Publication: 2024 Apr 03.
Autor:
de La Vega MA; Département de microbiologie-infectiologie et d'immunologie, Université Laval, Québec, Québec, Canada., Wong G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Wei H; Institute of Infectious Disease, Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China., He S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Bello A; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Fausther-Bovendo H; Département de microbiologie-infectiologie et d'immunologie, Université Laval, Québec, Québec, Canada., Audet J; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Tierney K; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Tran K; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Soule G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Racine T; Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Strong JE; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Kobinger GP; Département de microbiologie-infectiologie et d'immunologie, Université Laval, Québec, Québec, Canada.; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania,USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 Sep 04; Vol. 226 (4), pp. 616-624.
Autor:
Diallo I; Centre Hospitalier Universitaire de Québec Research Center/CHUL Pavilion, Quebec, QC G1V 4G2, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada., Husseini Z; Centre Hospitalier Universitaire de Québec Research Center/CHUL Pavilion, Quebec, QC G1V 4G2, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada., Guellal S; Centre Hospitalier Universitaire de Québec Research Center/CHUL Pavilion, Quebec, QC G1V 4G2, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada., Vion E; Centre Hospitalier Universitaire de Québec Research Center/CHUL Pavilion, Quebec, QC G1V 4G2, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada., Ho J; Centre Hospitalier Universitaire de Québec Research Center/CHUL Pavilion, Quebec, QC G1V 4G2, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada., Kozak RA; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3B 3M9, Canada.; Division of Microbiology, Department of Laboratory Medicine & Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada., Kobinger GP; Galveston National Laboratory, Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77550, USA., Provost P; Centre Hospitalier Universitaire de Québec Research Center/CHUL Pavilion, Quebec, QC G1V 4G2, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2022 May 07; Vol. 23 (9). Date of Electronic Publication: 2022 May 07.
Autor:
Diallo I; CHU de Québec Research Center, Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada., Ho J; CHU de Québec Research Center, Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada., Laffont B; CHU de Québec Research Center, Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada., Laugier J; CHU de Québec Research Center, Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada., Benmoussa A; CHU de Québec Research Center, Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada., Lambert M; CHU de Québec Research Center, Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada., Husseini Z; CHU de Québec Research Center, Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada., Soule G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3B 3M9, Canada., Kozak R; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3B 3M9, Canada.; Division of Microbiology, Department of Laboratory Medicine & Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada., Kobinger GP; CHU de Québec Research Center, Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada.; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3B 3M9, Canada.; Département de Microbiologie Médicale, Université du Manitoba, Winnipeg, MB R3E 0J9, Canada., Provost P; CHU de Québec Research Center, Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Quebec, QC G1V 4G2, Canada.; CHUQ Research Center/CHUL Pavilion, 2705 Blvd Laurier, Room T1-65, Quebec, QC G1V 4G2, Canada.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 06; Vol. 22 (7). Date of Electronic Publication: 2021 Apr 06.
Autor:
de La Vega MA; Département de microbiologie-infectiologie et immunologie, Université Laval, Quebec, QC G1V 4G2, Canada., Kobinger GP; Département de microbiologie-infectiologie et immunologie, Université Laval, Quebec, QC G1V 4G2, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Electronic address: gary.kobinger@crchudequebec.ulaval.ca.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Apr; Vol. 20 (4), pp. 388-389. Date of Electronic Publication: 2020 Jan 14.
Autor:
Nsio J; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Kapetshi J; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo., Makiala S; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo., Raymond F; Universite Laval, Quebec City, Canada., Tshapenda G; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Boucher N; Universite Laval, Quebec City, Canada., Corbeil J; Universite Laval, Quebec City, Canada., Okitandjate A; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Mbuyi G; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Kiyele M; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Mondonge V; World Health Organization (WHO), Kinshasa, Democratic Republic of the Congo., Kikoo MJ; World Health Organization (WHO), Kinshasa, Democratic Republic of the Congo., Van Herp M; Médecins sans Frontières (MSF), Geneva, Switzerland., Barboza P; WHO, Geneva, Switzerland., Petrucci R; Médecins sans Frontières (MSF), Geneva, Switzerland., Benedetti G; Medical Department, Operational Centre-Brussels, MSF, Luxembourg, Luxembourg., Formenty P; WHO, Geneva, Switzerland., Muyembe Muzinga B; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo., Ilunga Kalenga O; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Ahuka S; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo., Fausther-Bovendo H; Universite Laval, Quebec City, Canada., Ilunga BK; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Kobinger GP; Universite Laval, Quebec City, Canada., Muyembe JT; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2020 Feb 18; Vol. 221 (5), pp. 701-706.
Autor:
Patel A; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Reuschel EL; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Kraynyak KA; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Racine T; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Park DH; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Scott VL; College of Osteopathic Medicine, William Carey University, Hattiesburg, Mississippi., Audet J; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Amante D; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Wise MC; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Keaton AA; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Wong G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Villarreal DO; University of Pennsylvania, Philadelphia., Walters J; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Muthumani K; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Shedlock DJ; University of Pennsylvania, Philadelphia., de La Vega MA; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Plyler R; University of Pennsylvania, Philadelphia., Boyer J; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Broderick KE; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Yan J; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Khan AS; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Jones S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Bello A; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Soule G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Tran KN; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., He S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Tierney K; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Kobinger GP; University of Pennsylvania, Philadelphia.; Université Laval, Québec, Canada., Sardesai NY; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Weiner DB; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2019 Jan 29; Vol. 219 (4), pp. 544-555.
Autor:
Wong G; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba.; Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious Diseases, Shenzhen Third People's Hospital, China.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China., Leung A; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., He S; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba., Cao W; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., De La Vega MA; Département de Microbiologie-Infectiologie et d'Immunologie, Université Laval, Quebec City, Canada., Griffin BD; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Soule G; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba., Kobinger GP; Département de Microbiologie-Infectiologie et d'Immunologie, Université Laval, Quebec City, Canada., Kobasa D; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Qiu X; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2018 Nov 22; Vol. 218 (suppl_5), pp. S466-S470.
Autor:
Kapetshi J; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.; University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Fausther-Bovendo H; Laval University, Quebec, Quebec., Corbett C; Public Health Agency of Canada, Winnipeg, Manitoba., Leung A; Public Health Agency of Canada, Winnipeg, Manitoba., Ait-Ikhlef K; World Health Organization, Emerging and Dangerous Pathogens Laboratory Network, Geneva, Switzerland., Nsio J; Heath Ministry, Kinshasa, Democratic Republic of the Congo., Aruna A; Heath Ministry, Kinshasa, Democratic Republic of the Congo., Kebela Ilunga B; Heath Ministry, Kinshasa, Democratic Republic of the Congo., Muyembe JJ; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.; University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Formenty P; Heath Ministry, Kinshasa, Democratic Republic of the Congo., Kobinger GP; Laval University, Quebec, Quebec.; University of Pennsylvania School, Philadelphia.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2018 Nov 22; Vol. 218 (suppl_5), pp. S292-S296.
Autor:
Patel A; The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104, USA., Park DH; The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104, USA., Davis CW; Emory Vaccine Center, Emory University, Atlanta, GA 30317, USA., Smith TRF; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., Leung A; Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada., Tierney K; Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada., Bryan A; Integral Molecular, Philadelphia, PA 19104, USA., Davidson E; Integral Molecular, Philadelphia, PA 19104, USA., Yu X; The Scripps Research Institute, La Jolla, CA 92037, USA., Racine T; Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada; University of Manitoba, Winnipeg, MB R3T 2N2, Canada., Reed C; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., Gorman ME; The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104, USA; Boston College, Newton, MA 02467, USA., Wise MC; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., Elliott STC; The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104, USA., Esquivel R; The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104, USA., Yan J; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., Chen J; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., Muthumani K; The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104, USA., Doranz BJ; Integral Molecular, Philadelphia, PA 19104, USA., Saphire EO; The Scripps Research Institute, La Jolla, CA 92037, USA., Crowe JE; Vanderbilt University, Nashville, TN 37235, USA., Broderick KE; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., Kobinger GP; Université Laval, Quebec City, QC G1V 0A6, Canada., He S; Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada., Qiu X; Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada; University of Manitoba, Winnipeg, MB R3T 2N2, Canada., Kobasa D; Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada; University of Manitoba, Winnipeg, MB R3T 2N2, Canada., Humeau L; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., Sardesai NY; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA., Ahmed R; Emory Vaccine Center, Emory University, Atlanta, GA 30317, USA., Weiner DB; The Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104, USA. Electronic address: dweiner@wistar.org.
Publikováno v:
Cell reports [Cell Rep] 2018 Nov 13; Vol. 25 (7), pp. 1982-1993.e4.